BIO Financial Facts
Income from operations: 22.53MWeighted average common shares - diluted: 29.59M
See Full Income Statement
Finished goods: 300.07M
Property, plant and equipment, at cost: 1.18B
See Full Balance Sheet
Bio-Rad Laboratories, Inc. (BIO) Earnings
|
Expand Research on BIO
| Next EPS Date | 5/7/24 | EPS Growth Rate | -30.8% |
|---|---|---|---|
| Average EPS % Beat Rate | -1.6% | Revenue Growth Rate | -7.0% |
| Average % Move 1-Wk after EPS | -5.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/16/23 | Q422 | $3.31 | $3.47 | -$0.16 | $730.3M | $747.26M | N/A |  | | Details | |
| 2/10/22 |  |
Q421 | $3.21 | $2.87 | +$0.34 | $732.8M | $727.48M | N/A | | | Details |
| 8/3/23 | Q223 | $3.00 | $2.68 | +$0.32 | $681.1M | $697.96M | N/A | | | Details | |
| 5/4/23 | Q123 | $3.34 | $3.80 | -$0.46 | $677M | $696.08M | N/A | | | Details | |
| 10/26/23 | Q323 | $2.33 | $2.78 | -$0.45 | $632.1M | $689.5M | N/A | | | Details | |
| 2/11/21 | |
Q420 | $4.01 | $3.29 | +$0.72 | $789.8M | $686.8M | N/A | | | Details |
| 2/15/24 | Q423 | $3.10 | $2.82 | +$0.28 | $681.18M | $685M | N/A | | | Details | |
| 7/28/22 | Q222 | $3.38 | $2.80 | +$0.58 | $691.1M | $682.62M | N/A | | | Details |
